AVAH 8-K: Officer/Director Changes & Comp Arrangements Reported
Ticker: AVAH · Form: 8-K · Filed: Jan 17, 2024 · CIK: 1832332
| Field | Detail |
|---|---|
| Company | Aveanna Healthcare Holdings, Inc. (AVAH) |
| Form Type | 8-K |
| Filed Date | Jan 17, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.01, $240,000 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: executive-changes, compensation, corporate-governance
TL;DR
**AVAH filed an 8-K about executive changes and pay, details to follow.**
AI Summary
Aveanna Healthcare Holdings Inc. filed an 8-K on January 17, 2024, reporting an event that occurred on January 15, 2024, related to the departure or election of directors or officers and their compensatory arrangements. This filing indicates potential changes in leadership or executive compensation, which could impact the company's strategic direction and financial performance. Investors should monitor subsequent filings for details on who departed or was elected and the specifics of any new compensation plans, as these changes can influence investor confidence and the stock's future trajectory.
Why It Matters
Changes in leadership or executive compensation can signal shifts in company strategy or financial health, directly affecting investor sentiment and the stock's valuation.
Risk Assessment
Risk Level: medium — The filing indicates changes in leadership or compensation, which can introduce uncertainty until specific details are disclosed, potentially impacting the stock.
Analyst Insight
A smart investor would await further detailed disclosures regarding the specific personnel changes and compensation arrangements before making any investment decisions, as this filing is a preliminary notification.
Key Players & Entities
- Aveanna Healthcare Holdings Inc. (company) — the registrant filing the 8-K
- January 15, 2024 (date) — date of the earliest event reported
- January 17, 2024 (date) — date the 8-K was filed
- Delaware (company) — state of incorporation for Aveanna Healthcare Holdings Inc.
- AVAH (company) — trading symbol for Aveanna Healthcare Holdings Inc.
- The Nasdaq Global Select Market (company) — exchange where AVAH Common Stock is registered
Forward-Looking Statements
- Aveanna Healthcare Holdings Inc. will file a subsequent 8-K or proxy statement detailing the specific individuals involved in the reported officer/director changes and their compensation. (Aveanna Healthcare Holdings Inc.) — high confidence, target: 2024-03-31
FAQ
What specific event did Aveanna Healthcare Holdings Inc. report in this 8-K filing?
Aveanna Healthcare Holdings Inc. reported an event concerning the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers' as per Item Information.
When did the earliest event reported in this 8-K filing occur?
The earliest event reported in this 8-K filing occurred on January 15, 2024.
What is the trading symbol and the exchange where Aveanna Healthcare Holdings Inc.'s common stock is registered?
The trading symbol for Aveanna Healthcare Holdings Inc.'s common stock is AVAH, and it is registered on The Nasdaq Global Select Market.
What is the business address of Aveanna Healthcare Holdings Inc. as stated in the filing?
The business address of Aveanna Healthcare Holdings Inc. is 400 Interstate North Parkway SE, Atlanta, Georgia, 30339.
What is the purpose of an 8-K filing, as indicated by the form's title?
The form's title, 'CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934', indicates that an 8-K is used to report material current events that shareholders should know about.
Filing Stats: 957 words · 4 min read · ~3 pages · Grade level 14 · Accepted 2024-01-17 07:00:09
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share AVAH The Nasdaq Global Se
- $240,000 — s; (ii) a cash payment in the amount of $240,000, representing Mr. Drake’s annual
Filing Documents
- avah-20240115.htm (8-K) — 44KB
- avah-ex10_1.htm (EX-10.1) — 123KB
- img24668278_0.jpg (GRAPHIC) — 6KB
- 0000950170-24-004820.txt ( ) — 311KB
- avah-20240115.xsd (EX-101.SCH) — 23KB
- avah-20240115_htm.xml (XML) — 4KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 10.1 Separation and Transition Agreement, dated as of January 15, 2024, by and among Shannon Drake, Aveanna Healthcare LLC and Aveanna Healthcare Holdings Inc. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Aveanna Healthcare Holdings Inc. Date: January 17, 2024 By: /s/ Jeff Shaner Jeff Shaner Chief Executive Officer (Principal Executive Officer)